• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS INC. CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS INC. CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problems Fluid/Blood Leak (1250); Device Displays Incorrect Message (2591)
Patient Problem Insufficient Information (4580)
Event Date 09/08/2020
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction photoactivation module leak.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot j217 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot j217 shows no trends.Trends were reviewed for complaint categories, alarm #8: blood leak? (photoactivation chamber) and photoactivation module leak.No trends were detected for these complaint categories.The customer provided photographs for investigation.The smart card was not returned; therefore, the reported alarm #8: blood leak (photoactivation chamber) could not be verified.An alarm #8: blood leak (photoactivation chamber) occurs when the photoactivation chamber leak detector has detected a fluid leak.The provided photographs verify the photoactivation module leak as a crack near the center of the module is visible.The cause of the crack could not be determined from the photographs.A material trace of the photoactivation plates at incoming in process or through complaints used to build lot j217 did not find any previous non-conformances.A device history record review did not identify any related non-conformances and this kit lot had passed all lot release testing.A root cause for the photoactivation module leak could not be determined from the information provided.No further action required at this time.This investigation is now complete.(b)(4).
 
Event Description
The customer contacted mallinckrodt to report that they experienced a photoactivation module leak with their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.The customer reported approximately 1500 mls of whole blood had been processed when an alarm #8: blood leak? (photoactivation chamber) was received during the photoactivation phase of the treatment and the leak was observed in the photoactivation module.The customer aborted the ecp treatment and did not return residual blood within the kit to the patient.The patient was reported to be in stable condition.The customer discarded the kit and returned photographs for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS INC.
bedminster, nj
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin, D15 T X2V
EI   D15 TX2V
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, nj 
MDR Report Key10654659
MDR Text Key224637938
Report Number2523595-2020-00106
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 10/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/01/2022
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCLXECP
Device Lot NumberJ217
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/09/2020
Initial Date FDA Received10/09/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/23/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-